UAE ban on Diane 35
Abu Dhabi, February 6, 2013
The UAE's Ministry of Health has aksed local health authorities and directors of medical districts, public and private hospitals and private clinics to temporarily suspend the usage of Diane 35 due to its side effects.
The decision is based on the recommendations of the French Drugs Agency "ANSM" regarding the medicine and similar products that are used for the treatment of acne and other dermatology diseases which have a hormonal origin, a Wam report quoted the ministry as saying.
Studies showed that their usage may cause blood clots, the ministry said.
Dr Amin Hussein Al Amiri, assistant undersecretary for medical practices and licensing and chairman of the higher committee for registration and pricing, said: "The ministry recommended the temporary suspension of the above mentioned drug and all similar products in addition to the importation and marketing of the drug until the final evaluation of the product is done by international health authorities."
He also stated that patients using the drug should not stop using the medicines by themselves but consult their doctor. He noted that doctors must not prescribe new prescriptions or renew the prescription of the medicine.
More Health & Environment Stories
- BCC joins global drive on heart disease
- NBK to fund hospital expansion
- Oman launches ME-first solar driven oil recovery
- Bahrain launches major clean-up drive
- ‘Barely 50pc in Bahrain eat 3 meals a day’
- Ooredoo, Messi team up for children’s health
- Elan buys $40m stake in Dubai pharma group
- BA wins top business ethics awards
- MAF Dalkia inks service deal for TDIC project
- Schneider Electric unveils new solar products